Series Objectives Review the results of studies in myeloproliferative diseases, multiple myeloma, leukemia, lymphoma, and CAR-T cell therapy from ASCO 2026 and ASH 2025 Discuss recent data on...
Series Objectives 1. Evaluate how manufacturing, handling, and delivery variables influence MSC therapeutic mechanisms and clinical outcomes. 2. Discuss emerging evidence on MSCs and extracellular...